Fig1 (Norgestimate Fig1)
Vylibra Kit
Product Images NDC 50102-235
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Vylibra (NDC 50102-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig2 (Norgestimate Fig2)
Fig3 (Norgestimate Fig3)
This appears to be a list of various studies on women's contraceptive use, including the year of the study, whether it was ever use or current use, and some effect estimates. The text is not very clear, but it seems the studies were conducted between 2002 and 2017.*
Fig4 (Norgestimate Fig4)
This appears to be a chart or table comparing various methods of birth control and their effectiveness, as measured by the number of pregnancies per 100 women in one year. The methods listed include implants, injections, intrauterine devices (IUDs), sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The chart shows that these methods range in effectiveness from fewer than 1 pregnancy per 100 women per year to 1010 pregnancies per 100 women per year, with some methods being more effective than others.*
Fig5 (Norgestimate Fig5)
This text seems to include a label for a medication package, indicating day labels to be peeled and placed, dosage information, and a color-coding system to differentiate between different types of pills. No other information is available.*
Package Label-principal Display Panel (0.250 mg/0.035 mg Pouch Carton Label)
Norgestimate Fig7
This is a description of a pharmaceutical product with the brand name Afaxys. It contains tablets of Norgestimate and Ethinyl Estradiol, and is manufactured by Aurobindo Pharma Limited in India. The product has an NDC code of 50102-235-11. The rest of the text is not useful or readable.*
Chemical Structure (Norgestimate Str)
Ethinyl Estradiol is a synthetic hormone used in many hormonal birth control methods. It is a form of estrogen and works by preventing ovulation and thickening cervical mucus to block sperm from reaching an egg. Ethinyl Estradiol is commonly combined with progestin in birth control pills.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
